DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Bio Medica Laboratories Limited — Shareholders meeting

NSE 3d ago·27 Aug 2026, 12:22 pm

BMLL NSE

Bio Medica Laboratories Limited has submitted the Postal Ballot scrutinizer's report and announced the voting results to the stock exchange. This formal filing confirms the completion of the voting process for the resolutions put before the shareholders.

This announcement is a routine corporate governance step. It provides transparency regarding shareholder decisions on specific corporate matters, such as board appointments or policy changes. For investors, it confirms the outcome of the process without altering the company's fundamental business operations.

Investors should watch for the company's future disclosures regarding the resolutions that were passed or rejected. This information helps gauge the sentiment of the existing shareholder base regarding the company's strategic direction.